Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C β inhibitor, ruboxistaurin-Reference-Cited by-同舟云学术

Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C β inhibitor, ruboxistaurin

Published:2008-03 Issue:2 Volume:22 Page:88-95
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Brooks Belinda,Delaney-Robinson Carol,Molyneaux Lynda,Yue Dennis K.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference55 articles.

1. Diminished flare response in neuropathic diabetic patients. Comparison of effects of substance P, histamine, and capsaicin;Aronin;Diabetes,1987

2. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy;Arora;Diabetes Care,1998

3. Development and validity testing of the Neuropathy Total Symptom Score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy;Bastyr;Clinical Therapeutics,2005

4. Inhibition of protein kinase C beta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans;Beckman;Circulation Research,2002

5. Innervation of the vasa nervorum: Changes in human diabetics;Beggs;Journal of Neuropathology and Experimental Neurology,1992

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes;Journal of Diabetes and its Complications;2023-09

2. Metabolic Mechanisms in Diabetic Neuropathy;Contemporary Diabetes;2023

3. Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy?;Diagnostics;2022-03-17

4. The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy;Inflammopharmacology;2022-01-12

5. SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice;EBioMedicine;2020-11